Share-Based Compensation (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|---|
Aug. 27, 2021 |
Apr. 20, 2021 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
Share-Based Compensation (Details) [Line Items] | ||||||
Share-based compensation expenses related to restricted stock grants | $ 51,000 | $ 9,000 | $ 82,000 | $ 23,000 | ||
Number of shares issued (in Shares) | 315,000 | 300,000 | ||||
Grant date price per fair value (in Dollars per share) | $ 0.1 | $ 0.0631 | ||||
Grant date fair value | $ 31,500 | $ 163,100 | ||||
Restricted Stock [Member] | ||||||
Share-Based Compensation (Details) [Line Items] | ||||||
Number of shares issued (in Shares) | 790,000 | |||||
2015 Incentive Plan [Member] | ||||||
Share-Based Compensation (Details) [Line Items] | ||||||
Number of shares issued (in Shares) | 945,000 | |||||
Board of Directors [Member] | ||||||
Share-Based Compensation (Details) [Line Items] | ||||||
Number of shares issued (in Shares) | 550,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|